Physician profile
David S Levesque
NPI 1861429938
$2,653.64
in general payments reported to CMS, 2019-2025
16 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $122 · 2021: $97.42 · 2022: $927 · 2023: $570 · 2024: $217 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,104.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $243.92 | 2019-2024 | Oasis, Grafix Pl, Stravix |
| Zimmer Biomet Holdings, INC. | $241.59 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $240.58 | 2023-2025 | Nuzyra |
| Organogenesis INC. | $220.63 | 2019-2020 | |
| Abbott Laboratories | $216.59 | 2019-2023 | Proclaim |
| Tactile Systems Technology INC | $197.85 | 2025 | Flexitouch Plus, Nimbl |
| Kerecis Limited | $180.29 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Angiodynamics, INC. | $175.23 | 2022 | |
| Treace Medical Concepts, INC. | $127.89 | 2022 | |
| Royal Biologics, INC. | $122.15 | 2022 | |
| Paragon 28, INC. | $121.57 | 2022 | |
| Abbvie INC. | $121.55 | 2022 | |
| Grt US Holding, INC. | $120.82 | 2022 | |
| Urgo Medical North America, LLC | $117.94 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Stability Biologics, LLC | $107.62 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $97.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Levesque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.